AU2003260515A1 - Derivatives of 4-4'-bipyridyl-2-2'-bisoxazoles and 4-4'-bipyridyl-2-2'-bistiazoles as antineoplasic agents - Google Patents
Derivatives of 4-4'-bipyridyl-2-2'-bisoxazoles and 4-4'-bipyridyl-2-2'-bistiazoles as antineoplasic agentsInfo
- Publication number
- AU2003260515A1 AU2003260515A1 AU2003260515A AU2003260515A AU2003260515A1 AU 2003260515 A1 AU2003260515 A1 AU 2003260515A1 AU 2003260515 A AU2003260515 A AU 2003260515A AU 2003260515 A AU2003260515 A AU 2003260515A AU 2003260515 A1 AU2003260515 A1 AU 2003260515A1
- Authority
- AU
- Australia
- Prior art keywords
- bipyridyl
- bistiazoles
- bisoxazoles
- derivatives
- antineoplasic agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000000118 anti-neoplastic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ESP200201938 | 2002-08-16 | ||
| ES200201938A ES2200706B1 (en) | 2002-08-16 | 2002-08-16 | DERIVATIVES OF 4-4'-BIPIRIDIL-2-2'-BISOXAZOLES AND 4-4'-BIPIRIDIL-2-2'-BISTIAZOLES AS ANTINEOPLASICAL AGENTS. |
| PCT/ES2003/000424 WO2004016622A1 (en) | 2002-08-16 | 2003-08-14 | Derivatives of 4-4'-bipyridyl-2-2'-bisoxazoles and 4-4'-bipyridyl-2-2'-bistiazoles as antineoplasic agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2003260515A1 true AU2003260515A1 (en) | 2004-03-03 |
| AU2003260515A8 AU2003260515A8 (en) | 2004-03-03 |
Family
ID=31725576
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003260515A Abandoned AU2003260515A1 (en) | 2002-08-16 | 2003-08-14 | Derivatives of 4-4'-bipyridyl-2-2'-bisoxazoles and 4-4'-bipyridyl-2-2'-bistiazoles as antineoplasic agents |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2003260515A1 (en) |
| ES (1) | ES2200706B1 (en) |
| WO (1) | WO2004016622A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2344780B1 (en) * | 2009-03-03 | 2011-07-22 | Universidad De Barcelona | USEFUL BISTIAZOLIC COMPOUNDS FOR THE TREATMENT OF CANCER. |
| US8680126B2 (en) | 2010-09-02 | 2014-03-25 | Universitat De Barcelona | Fluorinated thiazoles for use in treating cancer |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3148194A (en) * | 1961-07-03 | 1964-09-08 | Arapahoe Chemicals Inc | Certain 1, 4-bis[2(4-substituted, 5-phenyloxazolyl)] benzenes |
| FR2066252A5 (en) * | 1970-10-20 | 1971-08-06 | Sumitomo Chemical Co | Oxazolyl optical brighteners for textiles and plastics |
| DD260698A1 (en) * | 1986-11-27 | 1988-10-05 | Tech Hochschule C Schorlemmer | METHOD FOR THE PRODUCTION OF BIS-OXAZOLIUM SALTS |
| JP2000318313A (en) * | 1999-05-07 | 2000-11-21 | Mitsui Chemicals Inc | Optical recording medium |
-
2002
- 2002-08-16 ES ES200201938A patent/ES2200706B1/en not_active Expired - Fee Related
-
2003
- 2003-08-14 AU AU2003260515A patent/AU2003260515A1/en not_active Abandoned
- 2003-08-14 WO PCT/ES2003/000424 patent/WO2004016622A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| ES2200706A1 (en) | 2004-03-01 |
| ES2200706B1 (en) | 2005-06-01 |
| AU2003260515A8 (en) | 2004-03-03 |
| WO2004016622A1 (en) | 2004-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003235676A1 (en) | Tricyclic-bis-enone derivatives and methods of use thereof | |
| AU2003259735A1 (en) | Small-mer compositions and methods of use | |
| AU2003217870A1 (en) | Pini-modulating compounds and methods of use thereof | |
| AU2003225669A1 (en) | Pin1-modulating compounds and methods of use thereof | |
| AU2003225668A1 (en) | Pin1-modulating compounds and methods of use thereof | |
| AU2003213673A1 (en) | Pin1-modulating compounds and methods of use thereof | |
| AU2003275311A1 (en) | Solid micro-perforators and methods of use | |
| AU4205100A (en) | Methods and compositions for the treatment of pancreatitis | |
| AU2003266321A1 (en) | Tetrahydropyrimidine-2-one derivatives and their uses | |
| AU2003223579A1 (en) | Combinations of cox-2 inhibitors and other agents for the treatment of parkinson's disease | |
| AU2003299441A1 (en) | Nf-hev compositions and methods of use | |
| AU2003260241A1 (en) | Buguzhi agent and composition and methods of preparing and administering the same | |
| AU2003278157A1 (en) | Novel phenylethanolamine derivatives and the use of the same as beta-3-agonists | |
| AU2003239868A1 (en) | Sunscreen compositions and methods of use thereof | |
| AU2003233445A1 (en) | Antimicrobial compositions and methods of use | |
| AU2003297612A1 (en) | 2-substituted-3-propenamide derivatives and methods of using the same | |
| AU2003205963A1 (en) | Azaphenylalanine derivatives and their use as antithrombotic agents | |
| AU2003287802A1 (en) | Palpometer and methods of use thereof | |
| AU2003206872A1 (en) | Derivatives of (1-benzyl-piperidine-4-yl)-diphenyl-methanol and their use as pesticide | |
| AU2003244455A1 (en) | Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases | |
| AU2002364911A1 (en) | Dmt-tic di- and tri-peptidic derivatives and related compositions and methods of use | |
| AU2003260515A1 (en) | Derivatives of 4-4'-bipyridyl-2-2'-bisoxazoles and 4-4'-bipyridyl-2-2'-bistiazoles as antineoplasic agents | |
| AU2003900495A0 (en) | Aroylhydrazone derivatives and therapeutic uses thereof | |
| AU2003291063A1 (en) | Antioxidant and antimicrobial agents and methods of use thereof | |
| WO2005042707A9 (en) | Taspasel 1 and methods of use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |